Literature DB >> 10458775

Inhibition of T cell apoptosis by IFN-beta rapidly reverses nuclear translocation of protein kinase C-delta.

D Scheel-Toellner1, D Pilling, A N Akbar, D Hardie, G Lombardi, M Salmon, J M Lord.   

Abstract

Type I interferons rescue activated human T cells from cytokine deprivation-induced apoptosis. Our data now show that IFN-beta also rapidly inhibits apoptotic signals induced through the Fas receptor (CD95) in human T cells. To identify upstream signaling elements that could be targets of IFN-beta, we have studied protein kinase C (PKC). PKC-delta is actively involved in the regulation of apoptosis and immunofluorescence staining revealed that early in apoptosis PKC-delta accumulated in the nucleus. Addition of IFN-beta to T cells already deprived of survival factors or treated with anti-Fas antibody caused a rapid retranslocation of PKC-delta away from the nucleus. Furthermore, the generation of a constitutively active catalytic fragment by cleavage of PKC-delta by caspase 3 occurred only after translocation of full-length PKC-delta to the nucleus. IFN-beta also inhibited caspase 3 and the proteolytic activation of PKC-delta. We conclude from these studies that nuclear translocation of PKC-delta is an early event in T cell apoptosis and that IFN-beta rapidly reverses this process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458775     DOI: 10.1002/(SICI)1521-4141(199908)29:08<2603::AID-IMMU2603>3.0.CO;2-L

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Characterization of the expanded T cell population in infectious mononucleosis: apoptosis, expression of apoptosis-related genes, and Epstein-Barr virus (EBV) status.

Authors:  C S Verbeke; U Wenthe; W F Bergler; H Zentgraf
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  The inhibition of cutaneous T cell apoptosis may prevent resolution of inflammation in atopic eczema.

Authors:  C H Orteu; M H Rustin; E O'Toole; C Sabin; M Salmon; L W Poulter; A N Akbar
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 3.  The peripheral generation of CD4+ CD25+ regulatory T cells.

Authors:  Arne N Akbar; Leonie S Taams; Mike Salmon; Milica Vukmanovic-Stejic
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

Review 4.  A novel, alternative pathway of apoptosis triggered through class II major histocompatibility complex molecules.

Authors:  Zoltan A Nagy; Nuala A Mooney
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

5.  The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells.

Authors:  Guangwu Xu; Yingyu Zhang; Liying Zhang; Guangwen Ren; Yufang Shi
Journal:  Biochem Biophys Res Commun       Date:  2007-07-20       Impact factor: 3.575

6.  Trophinin-mediated cell adhesion induces apoptosis of human endometrial epithelial cells through PKC-δ.

Authors:  Naoaki Tamura; Kazuhiro Sugihara; Tomoya O Akama; Michiko N Fukuda
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

7.  Positive feedback of protein kinase C proteolytic activation during apoptosis.

Authors:  Sabrina Leverrier; Alice Vallentin; Dominique Joubert
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

8.  Characterizing a soluble survival signal for activated lymphocytes from CD14+ cells.

Authors:  Xiaolei Tang; David E Yocum; David DeJonghe; Kathy Nordensson
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

9.  Control of Bcl-2 expression by reactive oxygen species.

Authors:  David A Hildeman; Thomas Mitchell; Bruce Aronow; Sara Wojciechowski; John Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

10.  Aggregated IgG inhibits the differentiation of human fibrocytes.

Authors:  Darrell Pilling; Nancy M Tucker; Richard H Gomer
Journal:  J Leukoc Biol       Date:  2006-03-16       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.